Cyalume Technologies Holdings, Inc.  

(Public, OTCMKTS:CYLU)   Watch this stock  
Find more results for Reneford Dale Baker�
0.0300
0.0000 (0.00%)
Delayed:   12:24PM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.02 - 0.28
Open     -
Vol / Avg. 0.00/13,133.00
Mkt cap 642,010.00
P/E     -
Div/yield     -
EPS -0.62
Shares 21.40M
Beta 7.34
Inst. own 17%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -0.47% -23.16%
Operating margin 10.37% -19.44%
EBITD margin - 28.47%
Return on average assets -0.43% -17.05%
Return on average equity - -501.10%
Employees 148 -
CDP Score - -

Address

96 Windsor St
WEST SPRINGFIELD, MA 01089-3528
United States - Map
+1-413-8582500 (Phone)

Website links

Description

Cyalume Technologies Holdings, Inc. (Cyalume) is a global technology-based manufacturer providing tactical and training solutions to the military of the United States and other select countries. The Company manufactures chemical light, reflective and battlefield effects simulator products. Cyalume provides various services including planning and implementing tactical training exercises simulating real world experiences. Its Chemiluminescent products come in varying shapes, sizes and functions and provide light in different colors, intensities and durations. The Company�s reflective products include items such as patches that can reflect white light or infrared light and reflective safety belts. The Company�s Battlefield effects simulator devices are designed to safely simulate the life threatening devices soldiers encounter on the battlefield.

Officers and directors

Thomas G. Rebar Chairman of the Board
Age: 51
Zivi R. Nedivi President, Chief Executive Officer, Director
Age: 55
Yaron Eitan Independent Vice Chairman of the Board
Age: 57
Michael J. Bielonko Chief Financial Officer
Age: 61
James G. Schleck MBA President of Cyalume Specialty Products, Director
Dale Baker Chief Operating Officer
Age: 56
Michael G. Barry Director
Ji Ham Director
Age: 38
Jason Epstein Independent Director
Age: 40
Andrew Intrater Independent Director
Age: 52